Barclays
AIFF

Barclays’s Firefly Neuroscience AIFF Stock Holding History

Barclays’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378 Buy
+312
New +$544 ﹤0.01% 5046

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Barclays's AIFF Position: Q2 2026 in Review

Barclays opened a new position in Firefly Neuroscience (AIFF) in Q2 2026: 312 shares worth $378. The stake represents ﹤0.01% of the portfolio and ranks #5046 among its holdings.

22 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Barclays held 312 shares of Firefly Neuroscience worth $378 as of Q2 2026.
  • Firefly Neuroscience was a new Barclays position in Q2 2026.
  • Firefly Neuroscience made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5046 holding.
  • 22 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.